Marex Group »

Fulcrum Therapeutics shares owned by Marex Group

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Marex Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $322k 42k 7.67

More positions owned by Marex Group

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom (AVGO)
Lumentum Hldgs Put Option (LITE)
Microsoft Corporation Call Option (MSFT)
Mastercard Incorporated Cl A Put Option (MA)
UnitedHealth (UNH)
Strategy Cl A New (MSTR)
Tesla Motors (TSLA)
Eli Lilly & Co. Put Option (LLY)
Goldman Sachs Put Option (GS)
Booking Holdings (BKNG)
Sandisk Corp (SNDK)
NVIDIA Corporation Call Option (NVDA)
Valkyrie Bitcoin (BRRR)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Marex Group

Top funds holding Fulcrum Therapeutics

Suvretta Capital Management
RA Capital Management
BlackRock
TCG Crossover Management
Vanguard Group
Braidwell
Nantahala Capital Management
Vanguard Capital Management
Standard Life Aberdeen
Balyasny Asset Management
Point72 Asset Management
Siren
First Turn Management
Jones Hill Capital
Adage Capital Partners GP

View all funds holding Fulcrum Therapeutics